First-line medications for neuropathic pain and allodynia include the following options
For anyone with cardiovascular risk factors, and the majority of people with obesity have at least one, this distinction between a medication that raises cardiovascular stress and one that reduces it is arguably more important than the weight loss difference itself
Abosi, O., Lopes, S., Schmitz, S
4.2 Cardiovascular benefits Cardiovascular outcome studies have shown substantial data validating the preventive benefits of GLP-1 receptor agonists (Fig
Other listed ingredients include delayed-release capsule (hypromellose), microcrystalline cellulose, magnesium stearate, and silicon dioxide